WG
SRRA

Winton Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Winton Group’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,421
Closed -$111K – 1583
2020
Q3 		$111K Buy
+10,421
New +$124K ﹤0.01% 1400
2020
Q1 		– Sell
-4,491
Closed -$62K – 1589
2019
Q4 		$62K Sell
4,491
-1,891
-30% -$24.7K ﹤0.01% 1501
2019
Q3 		$100K Buy
+6,382
New +$122K ﹤0.01% 1465

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Winton Group's SRRA Position: Q4 2020 in Review

Winton Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2020, closing a stake of 10,421 shares — an estimated $111K sold.

Winton Group first reported a position in SRRA in Q3 2019 and held it in 3 quarters. The position peaked at $111K in Q3 2020. 31 funds tracked by Wall St. Rank hold SRRA as of Q4 2020.

  • Winton Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Winton Group sold 10,421 Sierra Oncology, Inc. Common Stock shares in Q4 2020, an estimated $111K.
  • Winton Group first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Winton Group's Sierra Oncology, Inc. Common Stock position peaked at $111K in Q3 2020.
  • 31 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2020.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.